Abstract |
Metastasis accounts for the majority of cancer-related deaths. Transforming growth factor β (TGF-β) is believed to promote late-stage cancer progression and metastasis by inducing epithelial-mesenchymal transition (EMT). We previously reported that MS80, a novel oligosaccharide sulfate, inhibits TGF-β1-induced pulmonary fibrosis by binding TGF-β1. In our study MS80 effectively inhibited TGF-β/Smad signaling in lung cancer cells, breast cancer cells, and model cell lines. In addition, MS80 inhibited TGF-β1-induced EMT, motility, and invasion in vitro. Moreover, MS80 significantly inhibited lung metastasis in orthotopic 4T1 xenografts. Notably, the MS80 treatment significantly increased the infiltration of CD8(+) T cells and decreased the infiltration of regulatory T cells in primary tumors and spleens in mice bearing 4T1 xenografts. Therefore, MS80 is a novel and promising candidate for treating metastatic malignancies by targeting TGF-β1-induced EMT and mediating immunosuppression.
|
Authors | Ji Zhou, Wenjie You, Guangqiang Sun, Yixuan Li, Bi Chen, Jing Ai, Handong Jiang |
Journal | The Journal of pharmacology and experimental therapeutics
(J Pharmacol Exp Ther)
Vol. 359
Issue 1
Pg. 54-61
(10 2016)
ISSN: 1521-0103 [Electronic] United States |
PMID | 27432893
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics. |
Chemical References |
- MS80 oligosaccharide
- Oligosaccharides
- Smad Proteins
- Transforming Growth Factor beta1
|
Topics |
- Animals
- Apoptosis
(drug effects)
- CD8-Positive T-Lymphocytes
(drug effects, immunology)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Transformation, Neoplastic
- Epithelial-Mesenchymal Transition
(drug effects)
- Female
- Humans
- Mice
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Oligosaccharides
(pharmacology)
- Signal Transduction
(drug effects)
- Smad Proteins
(metabolism)
- Transforming Growth Factor beta1
(antagonists & inhibitors, pharmacology)
|